TITLE

Senescence suppressors: their practical importance in replicative lifespan extension in stem cells

AUTHOR(S)
Hwang, Eun
PUB. DATE
November 2014
SOURCE
Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However, their proliferative activity is destined to slow by replicative senescence, and the limited proliferative potential of MSCs not only hinders the preparation of sufficient cells for in vivo application, but also draws a limitation on their potential for differentiation. This calls for the development of safe and efficient means to increase the proliferative as well as differentiation potential of MSCs. Recent advances have led to a better understanding of the underlying mechanisms and significance of cellular senescence, facilitating ways to manipulate the replicative lifespan of a variety of primary cells, including MSCs. This paper introduces a class of proteins that function as senescence suppressors. Like tumor suppressors, these proteins are lost in senescence, while their forced expression delays the onset of senescence. Moreover, treatments that increase the expression or the activity of senescence suppressors, therefore, cause expansion of the replicative and differentiation potential of MSCs. The nature of the activities and putative underlying mechanisms of the senescence suppressors will be discussed to facilitate their evaluation.
ACCESSION #
98835978

 

Related Articles

  • Stem cell therapy: A novel & futuristic treatment modality for disaster injuries. Gurudutta, G. U.; Satija, Neeraj Kumar; Singh, Vimal Kishor; Verma, Yogesh Kumar; Gupta, Pallavi; Tripathi, R. P // Indian Journal of Medical Research;Jan2012, Vol. 135 Issue 1, p15 

    Stem cell therapy hold the potential to meet the demand for transplant cells/tissues needed for treating damages resulting from both natural and man-made disasters. Pluripotency makes embryonic stem cells and induced pluripotent stem cells ideal for use, but their teratogenic character is a...

  • Stem Cell Reality Check. Sparks, Carley // Horse Sport;2013 Horse Health Annual, p28 

    The article investigates the science and science fiction of stem cell therapy. It provides a brief history of stem cell therapy beginning from the discovery of the two kinds of stem cells in bone marrows. Three types of stem cells, the embryonic stem cells, mesenchymal stem cells and induced...

  • The Therapeutic Potential, Challenges and Future Clinical Directions of Stem Cells from the Wharton's Jelly of the Human Umbilical Cord. Bongso, Ariff; Fong, Chui-Yee // Stem Cell Reviews & Reports;Apr2013, Vol. 9 Issue 2, p226 

    Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the disadvantages of invasive isolation, limited cell numbers and ethical constraints while embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) face the clinical hurdles of potential immunorejection...

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Stemming Our Irrational Exuberance. Brenner, Malcolm K. // Molecular Therapy;Aug2011, Vol. 19 Issue 8, p1399 

    The author reflects on the technique to generate human embryonic stem cells (hESCs) and inducible pluripotent stem cells (iPSCs). He says that hESCs and iPSCs are genetically modified and has a major benefit for almost every disease. An overview of the argument regarding the bond issue for the...

  • Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs). Spinelli, valentina; Guillot, Pascale v.; Coppi, Paolo De // Organogenesis;Apr-Jun2013, Vol. 9 Issue 2, p101 

    Introduction: (1) Human embryonic stem (eS) cells are pluripotent but are diicult to be used for therapy because of immunological, oncological and ethical barriers. (2) Pluripotent cells exist in vivo, i.e., germ cells and epiblast cells but cannot be isolated without sacriicing the developing...

  • Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential. Zheng, Yu-Liang; Sun, Yang-Peng; Zhang, Hong; Liu, Wen-Jing; Jiang, Rui; Li, Wen-Yu; Zheng, You-Hua; Zhang, Zhi-Guang // PLoS ONE;12/9/2015, Vol. 10 Issue 12, p1 

    Induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) serve as a promising source for cell-based therapies in regenerative medicine. However, optimal methods for transforming iPSCs into MSCs and the characteristics of iPSC-MSCs obtained from different methods remain poorly...

  • Stem Cells in Pharmaceutical Biotechnology. Zuba-Surma, Ewa K.; Józkowicz, Alicja; Dulak, Józef // Current Pharmaceutical Biotechnology;Nov2011, Vol. 12 Issue 11, p1760 

    Multiple populations of stem cells have been indicated to potentially participate in regeneration of injured organs. Especially, embryonic stem cells (ESC) and recently inducible pluripotent stem cells (iPS) receive a marked attention from scientists and clinicians for regenerative medicine...

  • Keeping an eye on stem cells for studying disease modelling and cell-based therapy. Crombie, Duncan // Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19 

    The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics